UPCOMING SESSIONS in ET
Wed, Apr 1, 2026
10:00 – 11:00 PM UTC
Facing Fear & Pain in Amyloidosis: How to Take Back Control and Shorten the Storm Cath Jayasuriya Click To Register
UPCOMING SESSIONS in ET
Wed, Apr 1, 2026 · 10:00 – 11:00 PM UTC
Facing Fear & Pain in Amyloidosis: How to Take Back Control and Shorten the Storm
Cath Jayasuriya
Click To Register
View all sessions

Trusted Resources

Neurofilament Light Chain as a Biomarker of Hereditary Transthyretin-Mediated Amyloidosis
To identify changes in the proteome associated with onset and progression of hereditary transthyretin-mediated (hATTR) amyloidosis, also known as ATTRv amyloidosis…
Read more
Inotersen Preserves or Improves Quality of Life in Hereditary Transthyretin Amyloidosis
Hereditary transthyretin (hATTR) amyloidosis is a rare, systemic, progressive, debilitating, and fatal disease characterized by mutations in the gene encoding the…
Read more
Neuropathy Symptom and Change: Inotersen Treatment of Hereditary Transthyretin Amyloidosis
The content of this study was presented at the annual meeting of the American Academy of Neurology, May 2019, Philadelphia, Pennsylvania; the Fifth Congress of the…
Read more
AL Amyloidosis Week: A Patient’s Experience
This edition features the experience of AL amyloidosis patient Linda Woolfe. Linda has been diagnosed with AL amyloidosis for 5 years and faced a long wait until…
Read more
Transthyretin Amyloid Cardiomyopathy
Amyloidosis refers to a group of deposition diseases in which proteins with unstable structures misfold and aggregate into amyloid fibrils that deposit in different…
Read more
Amyloid Heart Disease
Amyloidosis refers to a group of diseases caused by deposits of abnormal proteins, known as amyloid, in one or more organs of the body. Deposition of amyloid in the…
Read more
Subscribe to